CGEN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Compugen · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 2.35 USD
3.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 54.4% of its 52-week range. The latest completed week returned 3.1%, after a 3.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. Options positioning is volatility with 58/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 43 out of 100
Latest Close 2.35 USD 31 Jul 2026
1W Return 3.1% latest completed week
4W Return 3.1% short-term follow-through
12W Return -19.0% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 43.20% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.1% Latest completed week; four-week move 3.1%. Indicator stack 52/35 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.20% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 58/100 conviction; expected move 38.9%. News sentiment 51/100 64 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.8% above the Trend Line and sits at 54.4% of its 52-week range. The latest completed week returned 3.1%, after a 3.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4012-week average 0.73

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.40Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.1% over four weeks, -19.0% over 12 weeks, and 58.8% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W3.1%
4W3.1%
12W-19.0%
26W27.7%
52W58.8%
Active trend streak4 weeks
Active weeks in one year36
Trend breadth69.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.90Latest activity-pressure read.
Pressure change14.0%Four-week change in activity pressure.
Leadership10.53Latest relative-leadership reading.
RS change105.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength99/100Blend of value, momentum, and quality. Underlying universe rank 2; rank 1 is best.
Value91/100Relative valuation strength. Underlying universe rank 10; rank 1 is best.
Quality97/100Profitability and accounting quality. Underlying universe rank 4; rank 1 is best.
Momentum84/100Medium-term price momentum. Underlying universe rank 17; rank 1 is best.
Growth90/100Revenue and earnings growth. Underlying universe rank 11; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework89/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
6.2x
Price divided by trailing earnings.
Price / sales
3.0x
Market value relative to trailing revenue.
EV / EBITDA
5.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
15.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
88.1%
Gross profit retained from each unit of revenue.
Operating margin
42.3%
Operating profit retained from revenue.
Free-cash-flow margin
44.0%
Free cash flow generated from revenue.
Return on invested capital
35.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
163.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-4.9%
Net share repurchases relative to market value.
Shareholder yield
-4.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CGEN shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 0.00, expected move of 38.9%, and Sharemaestro trend signal active.

Conviction58/100
Expected move38.9%
Put/call volume0.00
Pressure100
Speculation31
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 64 relevant articles.

11 positive · 45 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move38.9%Nearest-chain priced movement where available.
52-week drawdown-27.4%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+14.9%Week of 6 Mar.
Worst week-20.2%Week of 5 Jun.
Latest week+3.1%Week of 31 Jul.

Shape of recent returns

Strong gains11
Modest gains3
Flat weeks0
Modest losses6
Sharp losses6
Recent vol7.2%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew7.2% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape45/100

Trend, activity pressure, participation, and risk combine to a 45/100 tape read.

 Indicator analysis58/100

Latest 12-week confirmation: trend 10/12, activity pressure 5/12, relative leadership 8/12.

Activity pressure 0.40; No reversal markers Next-Week ExpectancyNegative 43.20%

Next-week expectancy is negative with a 43.20% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors92/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 82; Small Cap Core rank 31 SVQF89/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 83.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

CGEN shows volatility options pressure with a 58/100 conviction score, put-call volume ratio of 0.00, expected move of 38.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 38.9% Sentiment51/100

Weighted news tone is neutral across 64 relevant articles.

Earnings To Watch: Compugen Ltd (CGEN) Reports Q2 2026 Result Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.35 USD3.1%2.27 USD1.78 USD-0.9010.53996.5KOn
24 Jul 20262.28 USD-3.8%2.24 USD1.77 USD-0.888.321.1MOn
17 Jul 20262.37 USD-0.8%2.21 USD1.76 USD-0.9011.231.1MOn
10 Jul 20262.39 USD4.8%2.19 USD1.75 USD-0.987.951.5MOn
3 Jul 20262.28 USD9.1%2.16 USD1.75 USD-1.055.121.2MOff
26 Jun 20262.09 USD4.0%2.13 USD1.74 USD-0.93-2.801.2MOff
19 Jun 20262.01 USD-1.5%2.11 USD1.73 USD-0.50-10.771.4MOn
12 Jun 20262.04 USD-2.9%2.10 USD1.73 USD0.18-7.261.8MOn
5 Jun 20262.10 USD-20.2%2.08 USD1.72 USD0.80-2.513.5MOn
29 May 20262.63 USD-6.1%2.07 USD1.72 USD1.2516.371.7MOn
22 May 20262.80 USD1.8%2.04 USD1.71 USD1.4428.054.0MOn
15 May 20262.75 USD-5.2%2.01 USD1.70 USD1.4228.142.5MOn
8 May 20262.90 USD7.0%1.98 USD1.68 USD1.4435.732.1MOn
1 May 20262.71 USD-12.6%1.94 USD1.67 USD1.4535.103.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.